These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29464203)

  • 1. Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation-The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation.
    Yamada Y; Hoshino K; Fuchimoto Y; Matsubara K; Hibi T; Yagi H; Abe Y; Shinoda M; Kitago M; Obara H; Yagi T; Okajima H; Kaido T; Uemoto S; Suzuki T; Kubota K; Yoshizumi T; Maehara Y; Inomata Y; Kitagawa Y; Egawa H; Kuroda T
    Transplant Direct; 2018 Feb; 4(2):e342. PubMed ID: 29464203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO-incompatible kidney transplantation in elderly patients over 60 years of age.
    Uchida J; Iwai T; Machida Y; Kuwabara N; Kabei K; Murao M; Otoshi T; Naganuma T; Kumada N; Nakatani T
    Int Urol Nephrol; 2012 Oct; 44(5):1563-70. PubMed ID: 22828739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation.
    Maenosono R; Unagami K; Kakuta Y; Furusawa M; Okumi M; Azuma H; Ishida H; Tanabe K
    Int J Urol; 2019 Dec; 26(12):1114-1120. PubMed ID: 31522467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients - Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?
    Hsu SC; Thorat A; Jeng LB; Li PC; Chen TH; Yang HR; Poon KS
    Ann Transplant; 2020 Sep; 25():e923502. PubMed ID: 32943600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
    Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
    Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
    Tanabe K; Takahashi K; Sonda K; Tokumoto T; Ishikawa N; Kawai T; Fuchinoue S; Oshima T; Yagisawa T; Nakazawa H; Goya N; Koga S; Kawaguchi H; Ito K; Toma H; Agishi T; Ota K
    Transplantation; 1998 Jan; 65(2):224-8. PubMed ID: 9458019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation.
    Takahashi K; Saito K; Takahara S; Fuchinoue S; Yagisawa T; Aikawa A; Watarai Y; Yoshimura N; Tanabe K; Morozumi K; Shimazu M;
    Clin Exp Nephrol; 2017 Aug; 21(4):705-713. PubMed ID: 27534951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure.
    Shen T; Lin BY; Jia JJ; Wang ZY; Wang L; Ling Q; Geng L; Yan S; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):395-401. PubMed ID: 25100124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange.
    Kawagishi N; Satoh K; Enomoto Y; Akamatsu Y; Sekiguchi S; Fukumori T; Fujimori K; Satomi S
    Transplant Proc; 2005 Mar; 37(2):1205-6. PubMed ID: 15848670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation.
    Sugiyama K; Hyodo Y; Aikawa A
    Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation.
    Kim SH; Lee EC; Shim JR; Park SJ
    Liver Int; 2018 May; 38(5):932-939. PubMed ID: 29053910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoagglutinin adsorption in ABO-incompatible transplantation.
    Genberg H; Kumlien G; Wennberg L; Tydén G
    Transfus Apher Sci; 2010 Oct; 43(2):231-5. PubMed ID: 20667787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor.
    Kim JM; Kwon CH; Joh JW; Kang ES; Park JB; Lee JH; Kim SJ; Paik SW; Lee SK; Kim DW
    J Hepatol; 2013 Dec; 59(6):1215-22. PubMed ID: 23928408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab.
    Raut V; Mori A; Kaido T; Ogura Y; Taku I; Nagai K; Sasaki N; Endo K; Hata T; Yagi S; Egawa H; Uemoto S
    Transplantation; 2012 Jan; 93(1):99-105. PubMed ID: 22094955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of B, T, NK lymphocytes and isoagglutinin titers in ABO incompatible living donor liver transplantation using rituximab and basiliximab.
    Lee SD; Kim SH; Kong SY; Kim YK; Park SJ
    Transpl Immunol; 2015 Jan; 32(1):29-34. PubMed ID: 25449537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO-Incompatible Living Kidney Transplant Recipients from Spousal Donors Receiving Rituximab.
    Uchida J; Iwai T; Kabei K; Nishide S; Yamasaki T; Kuwabara N; Naganuma T; Kumada N; Takemoto Y; Nakatanti T
    Urol Int; 2016; 97(4):457-465. PubMed ID: 27732972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.
    Hamano I; Hatakeyama S; Fujita T; Murakami R; Hamaya T; Togashi K; Suzuki Y; Yamamoto H; Yoneyama T; Yoneyama T; Hashimoto Y; Narumi S; Tomita H; Ohyama C
    Transplant Proc; 2020; 52(6):1700-1704. PubMed ID: 32448659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
    J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.